Somatostatin with 99mTc and biodistribution studies in rats

Cancer Biotherapy and Radiopharmaceuticals

Volumn 22, Issue 6, 2007, Pages 748-754

  Acar, Çiǧdem ^a   Teksöz, Serap ^a   Ünak, Perihan ^a   Müftüler, F Zümrüt Biber ^a   Medine, E Ilker ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

99mTc; Bifunctional labeling; D PA (D penicillamine) and DTPA (diethylene triaminepentaacetic acid); Somatostatin

Indexed keywords

CHELATING AGENT; GROWTH HORMONE; PENICILLAMINE; PENTETIC ACID; SOMATOSTATIN; TECHNETIUM 99M; DRUG DERIVATIVE; TECHNETIUM; TECHNETIUM COMPLEX;

ANIMAL EXPERIMENT; ARTICLE; CANCER DIAGNOSIS; COMPLEX FORMATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG LABELING; DRUG STABILITY; DRUG UPTAKE; GALLBLADDER CONTRACTION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONAL REGULATION; ISOTOPE LABELING; NONHUMAN; PANCREAS SECRETION; PRIORITY JOURNAL; QUALITY CONTROL; RADIOCHROMATOGRAPHY; RAT; STOMACH ACID SECRETION; ANIMAL; CHEMISTRY; KIDNEY; LIVER; LUNG; MALE; METABOLISM; MUSCLE; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; CHELATING AGENTS; DRUG STABILITY; KIDNEY; LIVER; LUNG; MALE; MUSCLES; ORGANOTECHNETIUM COMPOUNDS; PENICILLAMINE; PENTETIC ACID; RATS; RATS, WISTAR; SOMATOSTATIN; TECHNETIUM; TISSUE DISTRIBUTION;

EID: 37549003220     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.0340     Document Type: Article

References (29)

1. Okarvi SM. Peptide-based radiopharmaceuticals: Future tools for diagnostic imaging of cancers and other diseases. Med Res Rev 2004;24:357.
2. 99mTc. Q C Nucl Med 1996;40:221.
3. Langer M, Beck-Sickinger AG. Peptides as carrier for tumor diagnosis and treatment. Curr Med Chem Anti-Cancer Agents 2001;1:71.
4. 99mTc: Effect of different concentration of reducing agents and amount of sodium pertechnetate on radiolabelling efficiency. Appl Radiat Isotop 2003;58:361.
5. Hongsheng B, J?n X, Cheng Z, et al. Labelling techniques of biomolecules for targeted radiotherapy. IAEA-TECDOC 2003; pp. :1359.
6. 3-octreotate in a small-cell lung cancer animal model. Cancer Biother Radiopharm 2005;20:2.
7. Weiner RE, Thakur ML. Radiolabeled peptides in the diagnosis and therapy of oncological diseases. Appl Radiat Isotop 2002;57:749.
8. 99mTc-complexes of pyridoxal with glutamate (Tc-PG) and isoleucine (Tc-PI). Eur J Nucl Med 1981;6:573.
9. 99mTc complex of ethylenediamine-N,N-diacetic acid as a scintigraphic agent for tumors. Chem Pharm Bull 1983;31(9):3242.
10. Unak P, Tunc M, Duman Y. Labeling of penicillamine disulfide with technetium-99m. Appl Radiat Isot 1998;7:805.
11. Taylor A, Talner B. Relative renal accumulation of Tc-99m penicillamine as an index of differential renal function: Concise communication. J Nucl Med 1978;19:178.
12. 99mTc- penicillamine, a new cholescintigraphic agent. J Nucl Med 1971;8:652.
13. 99mTc radiopharmaceuticals. Ann Nucl Med 2002;16:79.
14. 111In-octreotide. J Nucl Med 2000;41:1114.
15. Sosabowski J, Melendez-Alafort L, Mather S. Radiolabelling of peptides for diagnosis and therapy of nononcological diseases. Q J Nucl Med. 2003;47:223.
16. Froidevaux S, Eberle A. Somatostatin analogs and radiopeptides in cancer therapy. Biopolymers 2002;66(3):161.
17. 0]octreotide. J Nucl Med 2003;44(1):98.
18. Heppeler A, Froidevaux S, Eberle AN, et al. Receptor targeting for tumor localization and therapy with radiopeptides. Curr Med Chem 2000;7:971.
19. Messer WS Jr. Peptide Hormones III. Online document at: www.neurosci.pharm.utoledo.edu/MBC3320/CRH. htm Last accessed on December 2, 2007.
20. Sela M, Zisman E. Different roles of D-amino acids in immune phenomena. FASEB J 1997;11:449.
21. Welch MJ, Redvanly CS. Handbook of Radiopharmaceuticals. New York: John Wiley & Sons Ltd. 2003:645.
22. Acar C, Teksöz S, Ünak P, et al. Investigation of new bifunctional agents: D-penicillamine. J Radioanal Nucl Chem 2007;273:3.
23. Hauser W, Atkins HL, Nelson KG, et al. Technetium-99m DTPA: A new radiopharmaceutical for brain and kidney scanning. Radiology 1970;94(3):679.
24. Schottelius M, Rau F, Reubi Jc, et al. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry. Bioconj Chem 2005;16:429.
25. Rogers BE, Anderson CJ, Connett JM. Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: Biodistribution and metabolism. Bioconj Chem 1996;74:511.
26. 111]In(III)-labeled D- or L- benzyldiethylenetriaminepentaacetic acid. J Med Chem 1997;40:3986.
27. 111I-labeled nonsulphated CCK-8 analog: A peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy. J Nucl Med 1999;40:2081.
28. 99mTc-labeled radiopharmaceuticals. Sem Nucl Med 1990;20(1):5.
29. 99mTc-exorphin C: A new peptide radiopharmaceutical for tumor imaging. J Radioanal Nucl Chem 2005;265(3):473.